1. bookVolumen 69 (2019): Edición 1 (March 2019)
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés
Acceso abierto

Solubilization of ibuprofen for freeze dried parenteral dosage forms

Publicado en línea: 07 Dec 2018
Volumen & Edición: Volumen 69 (2019) - Edición 1 (March 2019)
Páginas: 17 - 32
Aceptado: 09 Sep 2018
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés

1. P. Khadka, J. Ro, H. Kim, I. Kim, J. T. Kim, H. Kim, J. M. Cho, G. Yun and J. Lee, Pharmaceutical particle technologies: An approach to improve drug solubility, dissolution and bioavailability, Asian J. Pharm. Sci.9 (2014) 304–316; https://doi.org/10.1016/j.ajps.2014.05.00510.1016/j.ajps.2014.05.005Search in Google Scholar

2. K. T. Savjani, A. Gajjar and J. K. Savjani, Drug solubility: Importance and enhancement techniques, International Scholarly Research Network, ISRN Pharm.12 (2012). Article ID 195727; http://dx.doi.org/10.5402/2012/19572710.5402/2012/195727339948322830056Search in Google Scholar

3. A. Kotar, M. Kotar, P. Šket and J. Plavec, Potential of solid-state NMR and SEM in characterization of tablets of ibuprofen, Curr. Pharm. Anal.11 (2015) 124–130; https://doi.org/10.2174/157341291066614111123132510.2174/1573412910666141111231325Search in Google Scholar

4. A. G. Martinez, B. E. Rodrigez, A. P. Roca and A. M. Ruiz, Intravenous ibuprofen for treatment of post-operative pain: A multicenter, double blind, placebo-controlled, randomized clinical trial, Plos One11 (2016) 1–16; https://doi.org/10.1371/journal.pone.015400410.1371/journal.pone.0154004485949327152748Search in Google Scholar

5. J. Nerurkar, J. W. Beach, M. O. Park and H. W. Jun, Solubility of (±)-ibuprofen and S(+)-ibuprofen in the presence of cosolvents and cyclodextrins, Pharm. Dev. Technol.10 (2005) 413–421; https://doi.org/10.1081/PDT-5444610.1081/PDT-54446Search in Google Scholar

6. A. R. Fernandes, N. R. Ferreira, J. F. Fangueiro, A. C. Santos, F. J. Veiga, C. Cabral, A. M. Silva and E. B. Souto, Ibuprofen nanocrystals developed by 22 factorial design experiment: A new approach for poorly water-soluble drugs, Saudi Pharm. J.25 (2017) 1117–1124; https://doi.org/10.1016/j.jsps.2017.07.00410.1016/j.jsps.2017.07.004611111230166898Search in Google Scholar

7. K. Stoyanova, Z. Vinarov and S. Tcholakova, Improving ibuprofen solubility by surfactant-facilitated self-assembly into mixed micelles, J. Drug. Deliv. Sci. Tec.36 (2016) 208–215; https://doi.org/10.1016/j.jddst.2016.10.01110.1016/j.jddst.2016.10.011Search in Google Scholar

8. A. Tan, N. G. Eskandar, S. Rao and C. A. Prestidge, First in man bioavailability and tolerability studies of a silica-lipid hybrid (Lipoceramic) formulation: A phase I study with ibuprofen, Drug. Deliv. Trans. Re.4 (2014) 212–221; https://doi.org/10.1007/s13346-013-0172-910.1007/s13346-013-0172-925786876Search in Google Scholar

9. S. G. Potta, S. Minemi, R. K. Nukala, C. Peinado, D. A. Lamprou, A. Urquhart and D. Douroumis, Preparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubility, J. Microencapsul. 28 (2011) 74–81; http://doi.org/10.3109/02652048.2010.52994810.3109/02652048.2010.52994821171818Search in Google Scholar

10. S. Melzig, D. Niedbalka, C. Schilde and A. Kwade, Spray drying of amorphous ibuprofen nanoparticles for the production of granules with enhanced drug release, Colloids Surf. A Physicochem. Eng. Asp.536 (2018) 133–141; https://doi.org/10.1016/j.colsurfa.2017.07.02810.1016/j.colsurfa.2017.07.028Search in Google Scholar

11. D. Bolten, R. Lietzow and M. Türk, Solubility of ibuprofen, phytosterol, salicylic acid, and naproxen in aqueous solutions, Chem. Eng. Technol.36 (2013) 426–434; https://doi.org/10.1002/ceat.20120051010.1002/ceat.201200510Search in Google Scholar

12. A. A. Mamun, A. Masum, F. Sharmin, A. Islam and S. Reza, Enhancement of solubility and dissolution characteristics of ibuprofen by solid dispersion technique, Dhaka University, J. Pharm. Sci.11 (2012) 1–6; https://doi.org/10.3329/dujps.v11i1.1248010.3329/dujps.v11i1.12480Search in Google Scholar

13. M. M. Gupta, M. G. Patel, N. S. Patel and M. Kedawat, Enhancement of dissolution rate of ibuprofen by preparing solid dispersion using different methods, Int. J. Pharm. Pharm. Sci.3 (2011) 204–206.Search in Google Scholar

14. R. P. Dugar, B. Y. Gajera and R. H. Dave, Fusion method for solubility and dissolution rate enhancement of ibuprofen using block copolymer poloxamer 407, AAPS PharmSciTech.17 (2016) 1428–1440; http://doi.ord/10.1208/s12249-016-0482-610.1208/s12249-016-0482-6Search in Google Scholar

15. M. Dixit, P. Kulkarni, P. Selvam and S. Mohsin, Preparation and characterization of freeze dried crystals of ibuprofen, Int. Res. J. Pharm.2 (2011) 255–258.Search in Google Scholar

16. Karsono, J. Tanuwijaya and D. Fatma, Formulation of ibuprofen orally disintegrating tablets (ODTs) by lyophilization method using gelatin and mannitol, Int. J. PharmTech. Res.6 (2014) 996–1002.Search in Google Scholar

17. M. Di Cagno, P. C. Stein, N. Skalko-Basnet, M. Brandl and A. Bauer-Brandl, Solubilization of ibuprofen with β-cyclodextrin derivatives: Energetic and structural studies, J. Pharm. Biomed. Anal.55 (2011) 446–451; https://doi.org/10.1016/j.jpba.2011.02.02210.1016/j.jpba.2011.02.022Search in Google Scholar

18. K. Kagkadis, D. M. Rekkas, P. Dallas and N. H. Choulis, A freeze-dried injectable form of ibuprofen: development and optimisation using response surface methodology, PDA J. Pharm. Sci. Technol.50 (1996) 317–323; https://doi.org/10.1016/S0378-5173(97)00332-310.1016/S0378-5173(97)00332-3Search in Google Scholar

19. S. K. Patel, D. Kumar, A. P. Waghmode and A. S. Dhabale, Solubility enhancement of ibuprofen using hydrotopic agents, Int. J. Pharm. Life Sci.2 (2011) 542–545.Search in Google Scholar

20. S.-H. Park and H.-K. Choi, The effects of surfactants on the dissolution profiles of poorly water-soluble acidic drugs, Int. J. Pharm.321 (2006) 35–41; https://doi.org/10.1016/j.ijpharm.2006.05.00410.1016/j.ijpharm.2006.05.00416797892Search in Google Scholar

21. S. H. Soltanpour and A. Jouyban, Solubility of acetaminophen and ibuprofen in binary and ternary mixtures of polyethylene glycols 200 and 400, propylene glycol, and water at 25 °C, Chem. Eng. Commun.201 (2014) 1606–1619; https://doi.org/10.1080/00986445.2013.82160910.1080/00986445.2013.821609Search in Google Scholar

22. M. A. Filippa and E. I. Gasull, Ibuprofen solubility in pure organic solvents and aqueous mixtures of cosolvents: Interactions and thermodynamic parameters relating to the solvation process, Fluid Phase Equilibr.354 (2013) 185–190; https://doi.org/10.1016/j.fluid.2013.06.03210.1016/j.fluid.2013.06.032Search in Google Scholar

23. M. G. Volonte, P. D. Valora, A. Cingolani and M. Ferrara, Stability of ibuprofen in injection solutions, Am. J. Health-Syst. Ph.62 (2005) 630–633.10.1093/ajhp/62.6.63015757886Search in Google Scholar

24. T. Lee and Y. W. Wang, Initial salt screening procedures for manufacturing ibuprofen, Drug Dev. Ind. Pharm.35 (2009) 555–567; https://doi.org/10.1080/0363904080245945210.1080/0363904080245945219005918Search in Google Scholar

25. U.S. Food and Drug Administration; FDA Approved Drugs; Ibuprofen http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=ibuprofen&SearchType=BasicSearch; access date April 2017.Search in Google Scholar

26. The ABDA – Federal Union of German Associations of Pharmacists; access date April 2017.Search in Google Scholar

27. Highlights of prescribing information; NDA 022348 Caldolor; https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022348s010lbl.pdf; access date May 25, 2018.Search in Google Scholar

28. J. Manrique and F. Martinez, Solubility of ibuprofen in some ethanol + water cosolvent mixtures at several temperatures, Lat. Am. J. Pharm.26 (2007) 344–354.Search in Google Scholar

29. M. L Hart, D. P Do, R. A Ansari and S.A A. Rizvi, Brief overview of various approaches to enhance drug solubility, J. Dev. Drugs2 (2013) 1–7; https://doi.org/10.4172/2329-6631.100011510.4172/2329-6631.1000115Search in Google Scholar

30. J. N. Patel, D. M. Rathod, N. A. Patel and M. K. Modasiya, Techniques to improve the solubility of poorly soluble drugs, Int. J. Pharm. Life Sci.3 (2012) 1459–1469.Search in Google Scholar

31. G. G. Z. Zhang, S. Y. L. Paspal, R. Suryanarayanan and D. J. W. Grant, Racemic species of sodium ibuprofen: Characterization and Polymorphic Relationships, J. Pharm. Sci.92 (2003) 1356–1366; https://doi.org/10.1002/jps.1039310.1002/jps.10393Search in Google Scholar

32. J. C. Kasper and W. Friess, The freezing step in lyophilisation: Physico-chemical fundamentals, freezing methods and consequences on process performance and quality attributes of biopharmaceuticals, Eur. J. Pharmaceut. Biopharmaceut.78 (2011) 248–263; https://doi.org/10.1016/j.ejpb.2011.03.01010.1016/j.ejpb.2011.03.010Search in Google Scholar

33. R. C. Rowe, P. J. Sheskey and M. E. Quinn, Mannitol, Sodium chloride, Dextrose and Succrose, in Handbook of Pharmaceutical Excipients (Ed. R. C. Rowe), 6th ed., Pharmaceutical Press and American Pharmacists Association, London/Washington, UK/USA 2009, pp. 426, 641, 224 and 704.Search in Google Scholar

34. S. R.-Royo, A. Martin, A. L. Simplicio, A. Matias, G. Bansaghi and M. J. Cocero, Separation of ibuprofen enantiomers by diastereomic salt formation and antisolvente precipitation in supercritical carbon dioxide, Poster89, http://www.isasf.net/fileadmin/files/Docs/Graz/HtmlDir/Papers/P89.pdf; access date May 25, 2018Search in Google Scholar

35. M. Geppi, S. Guccione, G. Mollica, R. Pignatello and C. Veracini, Molecular properties of ibuprofen and its solid dispersions with eudragit RL100 studied by solid state nuclear magnetic resonance, Pharm. Res. 22 (2005) 1544–1555; https://doi.org/10.1007/s11095-005-6249-510.1007/s11095-005-6249-5Search in Google Scholar

36. F. G. Vogt, Characterization of pharmaceutical compounds by solid-state NMR, eMagRes.4 (2015) 255–268; https://doi.org/10.1002/9780470034590.emrstm139310.1002/9780470034590.emrstm1393Search in Google Scholar

37. R. K. Harris, Applications of solid-state NMR to pharmaceutical polymorphism and related matters, J. Pharm. Pharmacol.59 (2007) 225–239; https://doi.org/10.1211/jpp.59.2.000910.1211/jpp.59.2.0009Search in Google Scholar

38. T. Kitak, A. Dumičić, O. Planinšek, R. Šibanc and S. Srčič, Determination of solubility parameters of ibuprofen and ibuprofen lysinate, Molecules20 (2015) 21549–21568; https://doi.org/10.3390/molecules20121977710.3390/molecules201219777Search in Google Scholar

39. P. Bustamante, M. A. Peña and J. Barra, The modified extended Hansen method to determine partial solubility parameters of drug containing a single hydrogen bonding group and their sodium derivatives: benzoic acid/Na and ibuprofen/Na, Int. J. Pharm.194 (2000) 117–124; https://doi.org/10.1016/S0378-5173(99)00374-910.1016/S0378-5173(99)00374-9Search in Google Scholar

Artículos recomendados de Trend MD

Planifique su conferencia remota con Sciendo